Shang Hai Zheng Quan Bao·2026-01-29 19:42Group 1 - The company held its 17th (temporary) meeting of the 9th Board of Directors on January 29, 2026, to discuss participation in the pre-restructuring of Zhejiang Bangjie Holdings Group Co., Ltd. [2][10] - The company approved a proposal to participate as an interested investor in the public recruitment of restructuring investors for Bangjie Holdings, designating its wholly-owned subsidiary, Meinian Health Industry (Group) Co., Ltd., as the entity to acquire control of Bangjie Holdings post-restructuring [3][10] - The decision was made with unanimous support from all attending board members, and the transaction does not require shareholder approval as it falls within the board's authority [10] Group 2 - The pre-restructuring aims to integrate industry resources and expand business layout, with the company seeking to become the controlling shareholder of Bangjie Holdings after the restructuring [8][25] - Bangjie Holdings was placed under pre-restructuring by the Jinhua Intermediate People's Court on January 5, 2026, with temporary managers appointed to oversee the process [9][14] - The recruitment of restructuring investors aims to bring in entities with industrial synergy and financial strength to support Bangjie Holdings in improving its operational capabilities and resolving its debt crisis [14] Group 3 - Interested investors must meet specific qualifications, including being a legally established entity with good commercial reputation and no significant legal violations in the past three years [15][16] - The recruitment process includes a qualification review, and interested investors are required to pay a registration deposit of 20 million RMB to secure their participation [22][23] - The selection of restructuring investors will be conducted under supervision, and if only one qualified investor applies, they will automatically become the restructuring investor [23][24] Group 4 - The participation in Bangjie Holdings' pre-restructuring is seen as a strategic move for the company to enhance its healthcare ecosystem and improve its core competitiveness and sustainable profitability [25] - The funding for this investment will come from the company's own resources and will not adversely affect its daily operations or financial status [25]